Schechter Investment Advisors, LLC Seagen Inc. Transaction History

Schechter Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$191.51 - $216.16 $11,490 - $12,969	60 Added 5.33%	1,186 $251,000
Q2 2023 Jul 26, 2023	SELL	$187.64 - $206.25 $19,889 - $21,862	-106 Reduced 8.6%	1,126 $216,000
Q1 2023 Apr 28, 2023	BUY	$127.59 - $203.08 $157,190 - $250,194	1,232 New	1,232 $249,000
Q2 2022 Nov 03, 2022	BUY	$108.81 - $179.33 $204,562 - $337,140	1,880 New	1,880 $332,000
Q1 2022 Nov 18, 2022	BUY	$119.61 - $157.85 $190,299 - $251,139	1,591 New	1,591 $229,000

Q4 2021 Dec 27, 2022	BUY	$142.57 - $190.86 $220,413 - $295,069	1,546 New	1,546 $239,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Schechter Investment Advisors, LLC with notifications on news.